|
[1] HASAN HY,HINSHAW JL,BORMAN EJ,et al. Assessing normal growth of hepatic hemangiomas during long-term follow-up[J]. JAMA Surg,2014,149(12):1266-1271.
|
|
[2] JING L,LIANG H,CAIFENG L,et al. New recognition of the natural history and growth pattern of hepatic hemangioma in adults[J]. Hepatol Res,2016,46(8):727-733.
|
|
[3] GAO J,FAN RF,YANG JY,et al. Radiofrequency ablation for hepatic hemangiomas:A consensus from a Chinese panel of experts[J]. J Clin Hepatol,2017,33(9):1638-1645.(in Chinese)高君，范瑞芳，杨家印，等．肝血管瘤射频消融治疗(国内)专家共识[J]．临床肝胆病杂志，2017,33(9):1638-1645.
|
|
[4] GAO J,JI JS,DING XM,et al. Laparoscopic radiofrequency ablation for large subcapsular hepatic hemangiomas:Technical and clinical outcomes[J]. PLo S One,2016,11(2):0149755.
|
|
[5] YUGAWA K,YOSHIZUMI T,HARADA N,et al. Multiple hepatic sclerosing hemangiomas:A case report and review of the literature[J]. Surg Case Rep,2018,4(1):60.
|
|
[6] OZAKI K,YOSHIKAWA J,YAMAMOTO T,et al. Preoperative diagnosis of the sclerosed hemangioma of the liver using multimodality imaging findings:A case report[J]. Radiol Case Rep,2018,13(5):1025-1029.
|
|
[7] MIYAMOTO S,OSHITA A,DAIMARU Y,et al. Hepatic sclerosed hemangioma:A case report and review of the literature[J]. BMC Surg,2015,15:45.
|
|
[8] SUGO H,SEKINE Y,MIYANO S,et al. Hepatic sclerosing hemangioma with predominance of the sclerosed area mimicking a biliary cystadenocarcinoma[J]. Case Reports Hepatol,2018,2018:7353170.
|
|
[9] XU L,YANG X,KE S,et al. Resection as first-line therapy for large hepatic sclerosing hemangioma:A case report[J].Onco Targets Ther,2019,12:6839-6842.
|
|
[10] YANG JW,LI Y,XIE K,et al. Spontaneous rupture of hepatic epithelioid hemangioendothelioma:A case report[J]. World J Gastroenterol,2017,23(1):185-190.
|
|
[11] STUDER LL,SELBY DM. Hepatic epithelioid hemangioendothelioma[J]. Arch Pathol Lab Med,2018,142(2):263-267.
|
|
[12] LERUT J,IESARI S. Vascular tumours of the liver:A particular story[J]. Transl Gastroenterol Hepatol,2018,3:62.
|
|
[13] YOUSAF N,MARUZZO M,JUDSON I,et al. Systemic treatment options for epithelioid haemangioendothelioma:The royal marsden hospital experience[J]. Anticancer Res,2015,35(1):473-480.
|
|
[14] LERUT JP,ORLANDO G,ADAM R,et al. The place of liver transplantation in the treatment of hepatic epitheloid hemangioendothelioma:Report of the European liver transplant registry[J]. Ann Surg,2007,246(6):949-957.
|
|
[15] SEMENISTY V,NARODITSKY I,KEIDAR Z,et al. Pazopanib for metastatic pulmonary epithelioid hemangioendothelioma-a suitable treatment option:Case report and review of anti-angiogenic treatment options[J]. BMC Cancer,2015,15:402.
|
|
[16] CHEVREAU C,LE CESNE A,RAY-COQUARD I,et al. Sorafenib in patients with progressive epithelioid hemangioendothelioma:A phase 2 study by the French Sarcoma Group(GSF/GETO)[J]. Cancer,2013,119(14):2639-2644.
|
|
[17] AGULNIK M,YARBER JL,OKUNO SH,et al. An open-label,multicenter,phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas[J]. Ann Oncol,2013,24(1):257-263.
|
|
[18] LAKKIS Z,KIM S,DELABROUSSE E,et al. Metronomic cyclophosphamide:An alternative treatment for hepatic epithelioid hemangioendothelioma[J]. J Hepatol,2013,58(6):1254-1257.
|
|
[19] SOAPE MP,VERMA R,PAYNE JD,et al. Treatment of hepatic epithelioid hemangioendothelioma:Finding uses for thalidomide in a new era of medicine[J]. Case Rep Gastrointest Med,2015,2015:326795.
|
|
[20] KYRIAZOGLOU A,KOUTSOUKOS K,ZAGOURI F,et al. Metastatic hepatic epithelioid hemangioendothelioma treated with Olaratumab:A falling star rising?[J]. Ther Clin Risk Manag,2020,16:141-146.
|
|
[21] ZAVRAS N,DIMOPOULOU A,MACHAIRAS N,et al. Infantile hepatic hemangioma:Current state of the art,controversies,and perspectives[J]. Eur J Pediatr,2020,179(1):1-8.
|
|
[22] PARIA S,MENDIRATTA V,CHANDER R,et al. A study of serum vascular endothelial growth factor in infantile hemangiomas[J].Indian J Dermatol Venereol Leprol,2019,85(1):65-68.
|
|
[23] LI S,XU G,GAO F,et al. Expression and association of VEGF-Notch pathways in infantile hemangiomas[J]. Exp Ther Med,2017,14(4):3737-3743.
|
|
[24] FORD JR,GONZALEZ-BARLATAY J,VALENZUELA AA. Early orbital infantile hemangioma that emphasizes the importance of glucose-transporter-1(GLUT-1)[J]. Can J Ophthalmol,2018,53(2):58-60.
|
|
[25] EHMAN EC,TORBENSON MS,WELLS ML,et al. Hepatic tumors of vascular origin:Imaging appearances[J]. Abdom Radiol(NY),2018,43(8):1978-1990.
|
|
[26] KROWCHUK DP,FRIEDEN IJ,MANCINI AJ,et al. Clinical practice guideline for the management of infantile hemangiomas[J]. Pediatrics,2019,143(1):e20183475.
|
|
[27] ERNST L,GRABHORN E,BRINKERT F,et al. Infantile hepatic hemangioma:Avoiding unnecessary invasive procedures[J].Pediatr Gastroenterol Hepatol Nutr,2020,23(1):72-78.
|
|
[28] COPPOLA A,BIANCO G,ARDITO F,et al. Primary hepatic angiosarcoma[J]. ANZ J Surg,2018,88(1-2):e75-e76.
|
|
[29] WILSON GC,LLUIS N,NALESNIK MA,et al. Hepatic angiosarcoma:A multi-institutional,international experience with44 cases[J]. Ann Surg Oncol,2019,26(2):576-582.
|
|
[30] WANG J,LI Q,CUI YL,et al. Hepatic angiosarcoma:An analysis of 16 cases[J]. Chin J Hepatobiliary Surg,2006,12(8):532-535.(in Chinese)王健，李强，崔云龙，等．肝血管肉瘤:16例回顾[J]．中华肝胆外科杂志，2006,12(8):532-535.
|
|
[31] BONACCORSI-RIANI E,LERUT JP. Liver transplantation and vascular tumours[J]. Transpl Int,2010,23(7):686-691.
|
|
[32] LERUT JP,WEBER M,ORLANDO G,et al. Vascular and rare liver tumors:A good indication for liver transplantation?[J]. J Hepatol,2007,47(4):466-475.
|
|
[33] KIM HR,RHA SY,CHEON SH,et al. Clinical features and treatment outcomes of advanced stage primary hepatic angiosarcoma[J]. Ann Oncol,2009,20(4):780-787.
|
|
[34] SINDHU S,GIMBER LH,CRANMER L,et al. Angiosarcoma treated successfully with anti-PD-1 therapy-a case report[J]. J Immunother Cancer,2017,5(1):58.
|
|
[35] CHANG SD,SAKAMOTO GT. The role of radiosurgery for hemangiopericytomas[J]. Neurosurg Focus,2003,14(5):e14.
|
|
[36] DEL ROSARIO ML,SALEH A. Preoperative chemotherapy for congenital hemangiopericytoma and a review of the literature[J]. J Pediatr Hematol Oncol,1997,19(3):247-250.
|
|
[37] PARK MS,PATEL SR,LUDWIG JA,et al. Activity of temozolomide and bevacizumab in the treatment of locally advanced,recurrent,and metastatic hemangiopericytoma and malignant solitary fibrous tumor[J]. Cancer,2011,117(21):4939-4947.
|
|
[38] MAKI RG,D'ADAMO DR,KEOHAN ML,et al. Phase II study of sorafenib in patients with metastatic or recurrent sarcomas[J]. J Clin Oncol,2009,27(19):3133-3140.
|
|
[39] STACCHIOTTI S,NEGRI T,PALASSINI E,et al. Sunitinib malate and figitumumab in solitary fibrous tumor:Patterns and molecular bases of tumor response[J]. Mol Cancer Ther,2010,9(5):1286-1297.
|
|
[40] JUNG DH,HWANG S,HONG SM,et al. Clinico-pathological correlation of hepatic angiomyolipoma:A series of 23 resection cases[J]. ANZ J Surg,2018,88(1-2):60-65.
|
|
[41] LIU J,ZHANG CW,HONG DF,et al. Primary hepatic epithelioid angiomyolipoma:A malignant potential tumor which should be recognized[J]. World J Gastroenterol,2016,22(20):4908-4917.
|
|
[42] KUBO H,YAMAZAKI H,OKADA T,et al. Primary hepatic angiomyolipoma:Immunohistochemistry and electron microscopic observations:A case report[J]. J Med Case Rep,2017,11(1):76.
|
|
[43] GU T,WANG J,CHEN XQ,et al. Hepatic angiomyolipoma:A case report and literature review[J]. J Jilin Univ(Med Edit),2019,45(1):153-155,219.(in Chinese)顾腾，王江，陈晓倩，等．肝血管平滑肌脂肪瘤1例报告及文献复习[J]．吉林大学学报(医学版)，2019,45(1):153-155,219.
|
|
[44] HUANG YM,WEI PL,CHEN RJ. Epithelioid angiomyolipoma of the liver[J]. J Gastrointest Surg,2018,22(1):175-176.
|
|
[45] WANG WT,LI ZQ,ZHANG GH,et al. Liver transplantation for recurrent posthepatectomy malignant hepatic angiomyolipoma:A case report[J]. World J Gastroenterol,2015,21(12):3755-3758.
|
DownLoad: